UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                             ----------------------

                                    FORM 8-K

                                 CURRENT REPORT

                     PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

                              --------------------

        Date of report (Date of earliest event reported): March 17, 2006

                            Applied DNA Sciences, Inc
               (Exact Name of Registrant as Specified in Charter)


            Nevada                      002-90539                59-2262718
(State or Other Jurisdiction     (Commission File Number)      (IRS Employer
      of Incorporation)                                      Identification No.)


                       25 Health Sciences Drive, Suite 113
                           Stony Brook, New York 11790
               (Address of Principal Executive Offices) (Zip Code)

                                  631-444-6862
              (Registrant's telephone number, including area code)

                                 Not Applicable
          (Former Name or Former Address, if Changed Since Last Report)

Check  the  appropriate  box  below  if the  Form  8-K  filing  is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2 below):

|_|  Written  communications  pursuant to Rule 425 under the  Securities Act (17
     CFR 230.425)

|_|  Soliciting  material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
     240.14a-12)

|_|  Pre-commencement   communications  pursuant  to  Rule  14d-2(b)  under  the
     Exchange Act (17 CFR 240.14d- 2(b))

|_|  Pre-commencement   communications  pursuant  to  Rule  13e-4(c)  under  the
     Exchange Act (17 CFR 240.13e- 4(c))


Item 5.02 Departure of Directors or Principal  Officers;  Election of Directors;
Appointment of Principal Officers.

     (d) Election of Directors.  On March 17, 2006,  the board of directors (the
"Board") of Applied DNA Sciences, Inc. (the "Company") increased the size of the
Board to six members and appointed the following new directors:

     James Hayward, Chief Executive Officer of the Company;

     Sanford R. Simon;

     Yacov Shamash.

     There  are no  arrangements  or  understandings  between  any  of  the  new
directors and any other persons  pursuant to which each person was selected as a
director.  Board committee  assignments have not yet been determined for the new
directors.


Item 8.01  Other Events.

     In February 2005,  the Company  entered into an agreement with The Research
Foundation  of the State  University of New York acting on behalf of Stony Brook
University ("The Research Foundation") to support a project entitled "A Chimeric
Method and System  for DNA  Encryption  and  Authentication."  Pursuant  to this
agreement,  the Research Foundation made a grant of $79,005.77 to the Company to
support the project, which amount is payable over six months. Upon approval from
The  Research  Foundation,  the  Company  will  receive an  additional  grant of
$80,000,  payable  over one year.  The general  objective  of this project is to
further research of chimeric DNA methodology.

     See the disclosure under Item 5.02 above.


                                    SIGNATURE

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                              Applied DNA Sciences, Inc.
                                              (Registrant)



                                              By: /s/ James Hayward
                                                  -----------------
                                                  James Hayward
                                                  Chief Executive Officer



Date:  March 20, 2006